Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: GaitTrainer and Virtual Reality.
- Who it may be relevant to
- Registry conditions: Stroke, Central Nervous System Diseases. Basic parameters: 35 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The primary objective of this study is to evaluate the tolerance of the use of immersive virtual reality (VR) during robotic walking rehabilitation sessions by Gait Trainer (GT) in post-stroke patients. Secondary objectives aim to evaluate the motivation to participate in VR sessions compared to conventional sessions, the participants' sense of presence within the virtual environment, and the usability of the rehabilitation device created. Finally, we will report the actual walking time and number of steps stroke patients take in VR sessions and conventional sessions.
Detailed description
Robotic Assisted Gait Therapy using the GT has been shown to be effective in restoring gait to non-walking stroke patients. However, GaitTrainer rehabilitation sessions can result in fatigue, sling attachment discomfort, which can limit the duration, intensity and participation of patients. Immersive Virtual Reality (VR) via visio helmet is an innovative and playful approach that allows rehabilitation to focus on specific tasks, such as walking in controlled and environmentally friendly environments. Coupled with robotic assistance, it could promote patient adherence and active participation thanks to the presence of bio-feedback and its playful aspect. However, the GT has never been associated with a walking activity simulated by a VR system. VR can lead to adverse effects (i.e., cyberkinetosis) such as dizziness, nausea or headaches. Thus, it seems necessary to observe the tolerance of the virtual environment immersion during GT assisted walking rehabilitation sessions in stroke patients.
This protocol involves the recruitment of non-walking stroke participants who are being rehabilitated in a Physical Medicine and Rehabilitation (PMR) department and receiving Gait Trainer-assisted rehabilitation. The intervention will consist of Gait Trainer-assisted robotic walking rehabilitation sessions with and without the addition of an immersive VR device. Post-stroke patients will complete 3 conventional sessions (Gait Trainer alone) and 3 sessions with the VR device.
Interventions
- Other GaitTrainer and Virtual Reality
Realization of Gait Trainer-assisted robot walking rehabilitation sessions without and with the addition of an immersive VR device. The proposed virtual stage will be a natural space (i.e. forest) of 360°. The subject will be able to explore the environment without moving. The created scene represents a straight path crossing a landscape composed of different natural elements. A fluid movement is obtained with the help of two sensors (trackers) of the HTC Vive device, placed at the level of the
Primary outcome measures
- CyberKinetosis [Time frame: 2 weeks]
Secondary outcome measures (5)
- Motivation to participate in immersive VR sessions [Time frame: 2 weeks]
- Evaluation of the sense of presence within the Virtual environmet [Time frame: 2 weeks]
- usability of the immersive VR rehabilitation device [Time frame: 2 weeks]
- Assessment of walking time [Time frame: 2 weeks]
- Assessment of number of steps [Time frame: 2 weeks]
Eligibility criteria
Inclusion criteria
- Hemiparesis following a first ischemic or hemorrhagic stroke;
- subacute phase (15 days to 6 months);
- Aged 35 to 75 years;
- Non-walking subject (unable to walk 3 x 10 meters without human assistance or Functional Ambulation Classification ≤ 2);
- Benefiting from robot-assisted walking rehabilitation in the readaptation and physical medecin department of the Limoges University Hospital;
- Having the cognitive abilities to understand and follow simple verbal instructions (MMSE < 24 or BDAE < 2)
- Be able to give informed consent to participate in this study.
Exclusion criteria
- Have neurological and psychiatric conditions, other than stroke;
- Conditions contraindicating the use of virtual reality (e.g., epileptic disorders, major cerebellar syndrome).
- Inability to evolve in a virtual environment (MSSQ-Short > 26)
- Patient with acute cardiovascular and respiratory disorders;
- Patient who is subject to a legal protection measure or who is unable to give consent;
- Person deprived of liberty
- Person with high VR experience during the 5 years before stroke
- pregnant woman, breastfeeding woman
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
France · 1 center
- CHU de Limoges — Limoges
Identifiers
NCT: NCT06053619 · 87RI23_0006 (RAVIS)